Regulatory variants are often context specific, modulating gene expression in a subset of possible cellular states. Although these genetic effects can play important roles in disease, the molecular mechanisms underlying context specificity are poorly understood. Here, we identified shared quantitative trait loci (QTLs) for chromatin accessibility and gene expression in human macrophages exposed to IFNγ , Salmonella and IFNγ plus Salmonella. We observed that ~60% of stimulus-specific expression QTLs with a detectable effect on chromatin altered the chromatin accessibility in naive cells, thus suggesting that they perturb enhancer priming. Such variants probably influence binding of cell-type-specific transcription factors, such as PU.1, which can then indirectly alter the binding of stimulus-specific transcription factors, such as NF-κ B or STAT2. Thus, although chromatin accessibility assays are powerful for fine-mapping causal regulatory variants, detecting their downstream effects on gene expression will be challenging, requiring profiling of large numbers of stimulated cellular states and time points.
G enetic differences among individuals profoundly alter how individuals' immune cells respond to environmental stimuli 1 . At the molecular level, these differences manifest as expression QTLs (eQTLs) that alter the magnitude of gene-expression changes after stimulation (response eQTLs) [2] [3] [4] [5] [6] [7] . Although response eQTLs have been implicated in modulating the risk for complex immunologically mediated disorders 8, 9 , the molecular mechanisms that give rise to these context-specific effects are poorly understood. Most eQTLs also alter chromatin accessibility, thus presumably reflecting disruption of transcription factor (TF) binding 10 . Because cellular responses to external stimuli are regulated by stimulus-specific TFs, response eQTLs might directly disrupt the binding of stimulusspecific TFs (Fig. 1a) . In support of this model, several studies have found that response eQTLs are enriched at the binding sites of stimulation-specific TFs such as NF-κ B and STAT2 (refs [5] [6] [7] ). However, a single stimulus or developmental cue can upregulate alternate sets of genes in different cell types, even when the activated signaling pathways and TFs remain the same 11 . To explain these observations, multiple studies have proposed a hierarchical enhancer activation model [11] [12] [13] [14] under which cell-type-specific TFs bind a subset of enhancers without directly affecting target-gene expression. This enhancer 'priming' can facilitate subsequent activation by signal-specific TFs, thereby producing a cell-type-specific response (Fig. 1b) . Thus, genetic variants can modulate stimulus-specific effects on gene expression indirectly by altering the binding of a cell-typespecific TF, for example PU.1 in macrophages, that regulates chromatin accessibility (Fig. 1b) . However, the genome-wide prevalence of enhancer priming is currently unclear, because directed genomeediting studies have been limited to only a few loci 15, 16 . Previous studies have highlighted that profiling chromatin accessibility is a good proxy for measuring TF binding without necessarily identifying the underlying TFs involved 10, 17, 18 . Furthermore, TF binding can be predicted with high accuracy from chromatin accessibility data 19, 20 . Thus, shared genetic associations at the chromatin and gene-expression levels provide a powerful alternative to probe the relationships among enhancer accessibility, TF binding and gene transcription.
Results
Genetics of gene expression and chromatin accessibility. We focused on enhancer priming in the context of the human macrophage immune response. To ensure sufficient numbers of cells, we differentiated macrophages from a panel of 123 human induced pluripotent stem cell (iPSC) lines obtained from the HipSci project 21, 22 . We profiled gene expression (with RNA-seq) and chromatin accessibility (with assay for transposase-accessible chromatin using sequencing (ATAC-seq) 23 ) in a subset of 86 successfully differentiated lines (Supplementary Fig. 1 and Supplementary Table 1) in four experimental conditions: naive; 18-h stimulation with the cytokine IFNγ ; 5-h infection with Salmonella enterica serovar Typhimurium (Salmonella); and IFNγ stimulation followed by Salmonella infection (Fig. 1c) . We chose these stimuli because they activate distinct, well-characterized signaling pathways ( Fig. 1d and Supplementary  Fig. 2 ), and prestimulating macrophages with IFNγ before bacterial infection is known to lead to enhanced microbial killing and stronger activation of the inflammatory response 24, 25 . We identified common genetic variants associated with either gene expression (eQTLs) or chromatin accessibility (caQTLs). Using an allele-specific method implemented in RASQUAL 26 , we detected at least one QTL for up to 3,431 genes and 20,788 chromatin regions (caQTL regions) in each condition (10% false discovery rate (FDR); Supplementary Fig. 3 and Supplementary Fig. 4 ), 50-75% of which were shared among conditions ( Supplementary Fig. 3 ). In agreement with findings from a previous report Furthermore, only 8% of the caQTL regions overlapped annotated promoters, and 42% overlapped regions marked with acetylated histone H3 K27 modifications 25 in macrophages (Supplementary Note). Next, using a statistical interaction test followed by filtering on effect size, we identified 387 response eQTLs and 2,247 response caQTLs with a small or undetectable effect (fold change (FC) < 1.5) in the naive state that increased at least 1.5 fold after stimulation (Methods). The use of an interaction test meant that our analysis should have been robust to false-positive response QTLs that might have arisen because of, for example, weak, undetected QTLs in the naive cell state. We verified this robustness by downsampling from a larger monocyte response eQTL dataset from Fairfax et al. 3 (Supplementary Tables 2 and 3 , and Supplementary Fig. 6 ). These genetic effects displayed a variety of activity patterns ( Fig. 2a and Supplementary Fig. 7a ). Notably, 18% of the response eQTLs appeared only after the cells were exposed to both stimuli (cluster 1), a number exceeding the number that appeared after IFNγ stimulation alone (clusters 5 and 6). Response caQTL regions contained closed chromatin in the naive cells (median transcripts per million = 0.49) and became 3.8 fold more accessible only after the relevant stimulus ( Supplementary Fig. 7b ). Furthermore, response caQTLs were associated with disruption of stimulus-specific TF motifs ( Supplementary Fig. 7c ), thus suggesting that they are largely driven by TFs that bind DNA only after stimulation.
Enhancer priming in the macrophage immune response. To quantify the extent of enhancer priming in the macrophage immune response, we next focused on how response eQTLs manifest at the chromatin level. We grouped response eQTLs (Fig. 2a) on the basis of the condition (treatment with IFNγ , Salmonella or both) in which they had the largest effect size. We then used linkage disequilibrium (LD) (R 2 > 0.8) between the lead variants to identify 145 caQTL-eQTL pairs that were likely to be driven by the same causal variant (Methods). For example, we identified a QTL upstream of GP1BA that had no effect in naive cells but became simultaneously associated with chromatin accessibility and gene expression after IFNγ + Salmonella stimulation (Fig. 2d) . The lead caQTL variant (rs4486968) was predicted to disrupt an NF-κ B-binding motif ( Supplementary Fig. 8 ), thus illustrating how a caQTL can directly affect stimulus-specific TF binding and gene expression. In contrast, a genetic variant in an intron of NXPH2 modulated the accessibility of a regulatory element in both naive and stimulated cells but became associated with gene expression only after IFNγ stimulation (Fig. 2e) . Genome wide, we found that for approximately half of the response eQTLs with a linked caQTL, the caQTL was present in naive cells before stimulation (caQTL FC > 1.5), thus suggesting that many response eQTLs regulate gene expression indirectly by first modulating the extent of enhancer priming in naive cells (Fig. 2b) . One potential issue with our analysis is that using LD to identify eQTL-caQTL pairs might sometimes lead to false positives wherein two independent causal variants-one altering gene expression, the other altering chromatin accessibility-that are in strong LD with one another are mistaken for a single shared causal variant. We therefore performed a reverse analysis in which we asked how often response caQTLs were linked to eQTLs that were present in the naive state, reasoning that those were likely to be false positives. Using the same FC threshold described above, we estimated our falsepositive rate to be 15% (Fig. 2c) . In agreement with this estimate, we found that 117 of 145 caQTLs-eQTL pairs (81%) showed concordant direction of effect in the stimulated cells (Fig. 2b) . Furthermore, the difference in the number of eQTLs and caQTLs did not seem to bias our results ( Supplementary Fig. 9 ). With a more stringent FC threshold of two, the false-positive rate decreased further to 4% ( Supplementary Fig. 9 ), and the concordance in effect-size direction increased to 90%. Finally, we performed the same analysis on a set of 26 colocalizing caQTL-eQTL pairs and were able to confirm that most response eQTLs manifested as caQTLs in unstimulated cells (Supplementary Fig. 10 ). The heat maps are sorted by caQTL effect size in the naive condition (first column). The solid lines represent the 1.5-fold threshold above which the caQTLs were considered to be present in the naive condition. c, Comparison of our estimated rate of enhancer priming (caQTL precedes response eQTL) to a negative control (eQTL precedes a response caQTL). d, Associations among the rs4486968 variant, chromatin accessibility and gene expression (n = 84 independent donors) at the GP1BA locus. e, Associations among the rs7594476 variant, chromatin accessibility and gene expression (n = 84 independent donors) at the NXPH2 locus. FPM, fragments per million. The -log 10 P values in d and e were calculated by using a likelihood-ratio test implemented in RASQUAL. The caQTL analysis used n = 42 (N), n = 41 (I) and n = 31 (I + S) independent donors. Box plots show the medians (center lines) and the twenty-fifth and seventy-fifth percentiles (box edges), with whiskers extending to 1.5 times the interquartile range.
Multiple TFs such as PU.1, AP-1, and C/EBPα and C/EBPβ have been implicated in regulating enhancer priming in macrophages [11] [12] [13] . We speculated that response eQTLs that alter enhancer priming should be associated with disruption of the motifs of those TFs. To test this possibility, we focused on the 145 eQTL-caQTL pairs (137 unique caQTLs) identified above (Fig. 2b) . We found that PU.1 motifs were disrupted by 9 of 78 caQTLs present in the naive cells but were not disrupted by the 59 caQTLs that appeared together with the response eQTL (two-sided Fisher's exact test, P = 0.01). For example, the rs7594476 variant in the NXPH2 enhancer disrupted PU.1 binding in a direction consistent with the caQTL effect (Fig. 3a) . Although the PU.1 enrichment was only nominally significant and was not significant after multiple testing correction for the other TFs tested, our observation was consistent with the established role of PU.1 in defining the accessible chromatin landscape in macrophages that subsequently directs stimulation-specific TF binding [11] [12] [13] . Master caQTL region (E1) and two IFNγ -specific dependent regions (E2 and E3) are highlighted by gray shadows. FPM, fragments per million. e, Association between the rs7594476 variant and expression of NXPH2 and SPOPL genes before and after IFNγ stimulation (n = 84 independent donors). f, Associations among the rs7594476 variant, master caQTL region (E1) and two dependent regions (E2 and E3) before and after IFNγ stimulation (n = 42 and n = 41 independent donors, respectively). The -log 10 P values in a and d were calculated by using a likelihood-ratio test implemented in RASQUAL. Box plots show the medians (center lines) and the twenty-fifth and seventy-fifth percentiles (box edges), with whiskers extending to 1.5 times the interquartile range.
Genetic effects on multiple chromatin regions. Recent evidence has suggested that single genetic variants can modulate the activity of multiple regulatory elements within topologically associated domains [26] [27] [28] [29] . One plausible mechanism for these broad associations is that a single causal variant might directly regulate the accessibility of a 'master' region and subsequently influence neighboring 'dependent' regions 26 . We used caQTL summary statistics to heuristically identify likely master and dependent regions, assuming that the causal variant should reside within the master region itself and thus affect accessibility in dependent regions ( Fig. 3b and Methods). We found a notable example of such a relationship at the NXPH2 locus, where a putative causal variant in the master region was also associated with the accessibility of a neighboring dependent region after IFNγ stimulation (Fig. 3b) . Using this approach, we identified 2,934 dependent regions that belonged to 1,921 unique master regions (Fig. 3b) . Master region-dependent region pairs were enriched in topologically associated domains (odds ratio 1.5, two-sided Fisher's exact test P = 1.26 × 10
) (Supplementary Note) and in 95% of the cases, the caQTL had the same direction of effect on master and dependent regions. Whereas 77% of the master regions had a single dependent region only a few kilobases away ( Supplementary  Fig. 11 ), we found many loci where master peaks were associated with multiple regions of open chromatin (Fig. 3c) . One of the largest effects was observed at the NXPH2 locus introduced above, where we detected 18 dependent regions spanning 100 kb of DNA (Fig. 3c) , six of which appeared only after IFNγ stimulation (Fig. 3d,f) . Notably, the appearance of condition-specific dependent regions correlated with the caQTL becoming a response eQTL for both NXPH2 and SPOPL (Fig. 3e) , thus suggesting that some of these regions might be required for gene activation. Using a linear model followed by strict filtering (Methods), we found a total of 64 condition-specific dependent regions genome wide, two of which are highlighted in Supplementary Fig. 12 .
Colocalization with disease associations. Because they can be engineered with high efficiency, iPSC-derived cells are promising cellular models of disease. Similarly to previous studies 7 , this study showed that macrophage eQTLs and caQTLs were enriched in genomewide association study (GWAS) hits of multiple immunologically mediated disorders (Supplementary Fig. 13 and Supplementary  Table 4 ). However, observing a genome-wide enrichment has only limited utility, and detailed follow-up of a locus is justified only when there is evidence of a shared causal mechanism between GWAS and eQTL associations. Thus, we used coloc 30 to identify . Box plots show the medians (center line) and the twenty-fifth and seventy-fifth percentiles (box edges), with whiskers extending to 1.5 times the interquartile range.
cases in which the gene expression and trait association signals were consistent with a model of a single, shared causal variant. We identified 22 eQTLs (Supplementary Table 5 ) that showed evidence of colocalization (PP3 + PP4 > 0.8, PP4/PP3 > 9; PP3, posterior probability of a model with two distinct causal variants; PP4, posterior probability of a model with one common causal variant) with at least one disease (Methods). In agreement with the results of our enrichment analysis, we found the largest number of overlaps with inflammatory bowel disease 31 and rheumatoid arthritis 32 (Fig. 4a) . Interestingly, only 10 of 22 of the colocalized eQTLs were detected in the naive cells, and each additional stimulated state increased the number of overlaps by approximately 30% (Fig. 4b) . However, coloc does not directly test the condition specificity of colocalizations and is thus subject to false positives, owing to limited power. To estimate the severity of this issue, we repeated the analysis on the Fairfax dataset 3 and found that two-thirds of the additional overlaps were not detected in unstimulated cells even if the sample size was increased fivefold (Supplementary Fig. 14) . For example, we found an IFNγ + Salmonella-specific response eQTL for TRAF1 that colocalized with a rheumatoid arthritis GWAS hit ( Supplementary  Fig. 15 ). Although the same colocalization has previously been reported in whole blood 33 , our data highlight the environmental conditions in which the association is active. Furthermore, the same associations were specific to 2-h lipopolysaccharide (LPS) stimulation in the Fairfax dataset and were not detected in unstimulated monocytes, even with 414 samples (Supplementary Fig. 16 ).
Our analysis of enhancer priming suggested that many disease associations might manifest at the level of chromatin without having an apparent effect on expression. To explore this possibility further, we focused on colocalization between caQTLs and GWAS hits. We detected 24 caQTLs that colocalized with a GWAS hit (Supplementary Table 6 ), but only two of those also colocalized with an eQTL (PTK2B eQTL with Alzheimer's disease 34 ( Supplementary  Fig. 17 ) and WFS1 eQTL with type 2 diabetes 35 ). Because genes often have multiple independent eQTLs 36 , we reasoned that some caQTLs might be secondary eQTLs for their target genes. To capture these secondary effects, we first identified four additional genes that were associated with a caQTL lead variant at FDR < 10%, even though the caQTL and eQTL lead variants were not in strong LD (i.e., R 2 < 0.8). We repeated the colocalization analysis on these loci and identified two additional overlaps (Supplementary Table 5 ), including a secondary eQTL for CTSB that colocalized with a GWAS hit for systemic lupus erythematosus 37 (Fig. 4c) . Interestingly, although the CTSB eQTL appeared after IFNγ + Salmonella stimulation, the caQTL was already present in naive cells. Although some caQTL colocalization with eQTLs might remain undetected because of a lack of power, the CTSB example suggested that a fraction of disease-associated caQTLs might correspond to primed enhancers that regulate gene expression in some other yet-unknown conditions. Although most (22 of 24) of the caQTL overlaps with disease were detected in the naive cells (Fig. 4c) , this result was confounded by the smaller ATAC-seq sample size in Salmonella and IFNγ + Salmonella conditions, which limited our power to detect colocalizations ( Supplementary Fig. 14a ).
Discussion
Multiple reports have highlighted that, although disease loci from association studies are strongly enriched in gene-regulatory elements 38, 39 , a relatively small fraction of these loci are explained by known eQTLs, even those identified in trait-relevant tissues 33, 40, 41 . Moreover, a recent systematic analysis by the GTEx Consortium of more than 44 tissues from 449 individuals found that only 52% of the trait-associated variants colocalized with an eQTL in one or more tissues 42 . Our results suggest that one reason for this apparent contradiction may be that many disease-risk variants affect chromatin structure in a broad range of cellular states, but their effects on expression are highly context specific. This interpretation is further supported by studies of 3D chromatin structure linking GWAS loci to putative target genes but finding no observable effects on gene expression 43 , in particular because enhancer-promoter interactions are known to precede transcription 44, 45 . We believe that our results should have important implications for future studies of human disease. First, a large range of cellular states will probably need to be profiled to capture the effects of disease-associated variants on expression. Second, overlap of disease variants with open chromatin, although likely to be informative regarding the identity of the causal variant, may not be relatively useful predictors of the diseaserelevant cell state.
One limitation of our study is that we were underpowered to detect caQTLs. Although previous studies have estimated that more than 55% of eQTLs are also associated with changes in chromatin accessibility 10 , we were able to detect a linked caQTL for only 145 of 387 (37%) of our response eQTLs, thus limiting the number of enhancer priming events that we were able to detect. Another possibility is that a subset of the effects of response eQTLs may be mediated by chromatin-independent mechanisms such as stimulation-specific regulation of mRNA stability, which has been estimated to be responsible for the effects of ~10% of eQTLs 46 . Finally, we found that current colocalization methods are not well suited to assess the condition specificity of eQTL-disease overlaps and can lead to a large number (~30%) of false positives.
Although our results suggest that many human-disease-associated variants affect enhancer priming, the functional relevance of this effect is currently not well understood. First, enhancer priming may facilitate cell-type-specific responses to ubiquitous signals 11, 47, 48 . Although specificity can also be achieved through cooperative binding to newly established enhancers 49 , TFs differ in their intrinsic ability to bind closed chromatin 50 . Thus, enhancer priming might be a preferred mechanism of cooperation between 'pioneer' TFs, which can independently open up chromatin (for example, PU.1 in macrophages), and 'settlers' (for example, NF-κ B), which predominantly bind accessible regions 20 . Alternatively, enhancer priming might facilitate rapid response to external stimuli. In support of this model, promoters of immediate early response genes are already accessible in naive cells 51 , and TF binding to primed enhancers peaks minutes after stimulation, whereas the activation of de novo enhancers can take several hours 49 . Thus, response eQTLs that appear rapidly after stimulation might be enriched in primed enhancers relative to those that appear later. Finally, enhancer priming might not be limited to single regulatory elements. Our results (Fig. 3d) together with those of previous reports 16, 52 suggest that some regulatory elements can act as 'seed' enhancers that allow other neighboring enhancers to become active after stimulation and lead to upregulation of gene expression. Although we identified a small number of such examples, future caQTL mapping studies in multiple cell types and conditions have the potential to systematically identify and characterize these hierarchical relationships among enhancers.
In summary, our results illustrate how preexisting genetic effects on chromatin propagate to gene expression during immune activation and additionally highlight the relevance of these hidden genetic effects in deciphering the molecular architecture of disease-associated variants. Our study also used iPSC-derived cells to study genetic effects in immune response. We believe that a major future use of this system will be the systematic exploration of gene-environment interactions across large numbers of cell states. Furthermore, because iPSCs are readily engineered, the identity of causal variants and their downstream consequences can be directly tested in exactly the same cell types and conditions in which they were discovered.
URLs. Data analysis scripts, https://github.com/kauralasoo/macrophage-gxe-study/; processed data, https://zenodo.org/communi-ties/macrophage-gene-expression-genetics/; wiggleplotr, https:// bioconductor.org/packages/wiggleplotr/; rasqualTools, https:// github.com/kauralasoo/rasqual/; NIHR Cambridge BioResource, http://www.cambridgebioresource.org.uk/.
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Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0046-7.
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an overview of signals, mechanisms and functions. Fig. 1 ). However, some of the differentiated lines did not produce enough macrophages to allow us to perform all of the experimental assays, or the differentiated cells were not sufficiently pure to be used in stimulation experiments. In total, we obtained high-quality RNA-seq data from 89 differentiations corresponding to 85 unique donors and ATAC-seq data from up to 42 unique donors in up to four experimental conditions (Supplementary Table 1 ). The final sample size was decided on the basis of similar gene-expression and chromatin QTL-mapping studies performed previously 2, 7, [26] [27] [28] . RNA-seq preprocessing and quality control. RNA-seq reads were aligned to the GRCh38 reference genome and Ensembl 79 transcript annotations by using STAR v2.4.0j 56 . Subsequently, VerifyBamID v1.1.2 (ref. 57 ) was used to detect and correct any potential sample swaps and cross-contamination between donors. We did not detect any cross-contamination, but we did identify one sample swap between two donors. We used featureCounts v1.5.0 (ref. 58 ) to count the number of uniquely mapping fragments overlapping GENCODE 59 basic annotation from Ensembl 79. We excluded short RNAs and pseudogenes from the analysis, thus leaving 35,033 unique genes of which 19,796 were protein coding. Furthermore, we used only 15,797 genes with mean expression in at least one of the conditions greater than 0.5 transcripts per million (ref. 60 ) in all downstream analyses. We quantile-normalized the data and corrected for sample-specific GC-content bias by using the conditional quantile normalization (cqn) 61 R package. To detect hidden confounders in gene expression, we applied PEER 62 to each condition separately, allowing for up to ten hidden factors. We found that the first three to five factors explained the most variation in the data, and the others remained close to zero. Although we performed replicate macrophage differentiations and RNA-seq from four iPSC lines, for simplicity we decided to use only one of the replicates in downstream analyses. We further excluded samples from one donor (qaqx_1) from downstream analysis because they appeared as outliers in principal component analysis. The final dataset consisted of 336 RNA-seq samples from 84 donors.
ATAC-seq data analysis. Read alignment. Illumina Nextera sequencing adapters were trimmed with skewer v0.1.127 (ref. 63 ) in paired-end mode. Trimmed reads were aligned to the GRCh38 human reference genome with bwa mem v0.7.12 (ref. 64 ). Reads mapping to the mitochondrial genome and alternative contigs were excluded from all downstream analysis. Picard 1.134 MarkDuplicates was used to remove duplicate fragments. We used verifyBamID 57 1.1.2 to detect and correct potential sample swaps between individuals. Fragment-coverage BigWig files were constructed with bedtools v2.17.0 (ref. 65 ).
Peak calling. We used MACS2 (ref. 66 ) v2.1.0 with '--nomodel --shift − 25 --extsize 50 -q 0.01' to identify open chromatin regions (peaks) that were enriched in transposase-integration sites relative to the background at the 1% FDR level. With these parameters, we detected between 31,658 and 208,330 peaks per sample. We constructed consensus peak sets in each condition separately by pooling all of the peak calls from all of the samples. For each peak, we first counted the number of samples in which that peak was identified. We then calculated the union of all peaks detected in at least three samples. Finally, we pooled the consensus peaks from all four conditions to obtain the final set of 296,220 unique peaks used in all downstream analyses. We used featureCounts 58 v.1.5.0 to count the number of fragments overlapping consensus peak annotations and used ASEReadCounter 67 from the Genome Analysis ToolKit to quantify allele-specific chromatin accessibility.
Sample quality control. We used the following criteria summarized in Supplementary Table 8 to assess the quality of ATAC-seq samples: 1. Assigned fragment count: the total number of paired-end fragments assigned to peaks by featureCounts 2. Mitochondrial fraction: the fraction of total fragments aligned to the mitochondrial genome 3. Assigned fraction: the fraction of nonmitochondrial reads assigned to consensus peaks (a measure of signal-to-noise ratio) 4. Duplicated fraction: the fraction of fragments that were marked as duplicates by Picard MarkDuplicates 5. Peak count: the number of peaks called by MACS2 6. Length ratio: the number of short fragments (< 150 nt) divided by the number of long fragments (≥ 150 nt) (a measure of whether the read-length distribution has a characteristic ATAC-seq profile with clearly visible mononucleosomal and dinucleosomal peaks). We used these criteria to exclude five samples from downstream analysis (Supplementary Table 8 ). One sample was excluded because of a very low assigned fraction (~10%) and peak count, and two more samples were excluded because of an extremely large length ratio (> 7) and a fragment-length distribution uncharacteristic for ATAC-seq libraries. The final two samples were excluded because they appeared to be outliers in the principal component analysis.
QTL mapping.
Preparing genotype data. We obtained imputed genotypes for all of the samples from the HipSci 22 project. We used CrossMap v0.1.8 (ref. 68 ) to convert variant coordinates from the GRCh37 reference genome to GRCh38. Subsequently, we filtered the VCF file with bcftools v.1.2 to retain only biallelic variants (both SNPs and indels) with IMP2 score > 0.4 and minor allele frequency > 0.05 in our 86 samples. The same VCF file was used for all subsequent analyses. The VCF file was imported into R with the SNPRelate 69 package.
Quantifying allele-specific expression and chromatin accessibility. We used ASEReadCounter 67 from the Genome Analysis ToolKit to count the number of allele-specific fragments overlapping each variant in the RNA-seq and ATAC-seq datasets. We used the following flags with ASEReadCounter: '-U ALLOW_N_ CIGAR_READS -dt NONE --minMappingQuality 10 -rf MateSameStrand' . We removed indels from the VCF file before quantifying allele-specific expression, because they are not supported by the RASQUAL model.
Detecting QTLs in RASQUAL.
We wrote a collection of Python scripts and a rasqualTools R package to simplify running RASQUAL on large numbers of samples and to work with large RASQUAL output files (URLs). We used the vcfAddASE.py script to add allele-specific counts calculated in the previous step into the VCF file. We ran RASQUAL 26 independently for each experimental condition, using sex and the first two PEER factors as covariates (sex and the first three principal components for caQTLs). In this model, in contrast to the standard linear model, covariates seemed to have only a minor effect on the number of QTLs detected by RASQUAL. We included only variants that were either in the gene body or within ± 500 kb from the gene (± 50 kb from the accessible region). We specified '--imputation-quality > 0.7' . As a result, variants with imputation quality < 0.7 were used as feature SNPs in allele-specific analysis but were not considered as possible causal variants. We also used RASQUAL's GC-correction option to correct for sample-specific GC bias in the feature-level read-count data. To correct for multiple testing, we picked one minimal P value per feature, used eigenMT 70 to estimate the number of independent tests performed in the cis region of each feature and then performed Bonferroni correction to obtain the corrected P values. We also ran RASQUAL once with the '--random-permutation' option to obtain empirical null P values from data with permuted sample labels. We performed the same eigenMT multiple testing procedure on the permuted P values and compared the true association P values to the empirical null distribution to identify QTLs with FDR < 10%.
Detecting QTLs by using a linear model. We used linear regression implemented in the FastQTL 55 software to map cis-QTLs in each experimental condition. We used the '--permute 100 10000' option to obtain permutation P values for each association. The size of the cis windows was set to ± 500 kb around each gene and ± 50 kb around each ATAC-seq peak. Before QTL mapping, the read-count data were quantile normalized in the cqn package, and the GC content of the feature (gene or peak) was included as a covariate. For eQTL analysis, we used sex and the first six PEER factors as covariates in the model. For caQTL analysis, we used sex and the first three principal components as covariates in the model. Although FastQTL reported feature-level permutation P values, obtaining those values was computationally not feasible in RASQUAL. Therefore, to be able to faithfully compare the number of QTLs detected by FastQTL and RASQUAL, we applied exactly the same multiple-testing-correction procedure (eigenMT + single permutation of sample labels) to both methods. We further restricted the comparison to features that were tested by both methods. This procedure affected a small number of genes that were tested by FastQTL but were filtered out by RASQUAL, because the raw read count was exactly zero in all samples.
Detecting response eQTLs. In each condition, we first identified all genes and corresponding lead variants that displayed significant association at the 10% FDR level from RASQUAL. For each gene, we kept only independent lead variants (R 2 < 0.8). Finally, we used all independent pairs of genes and corresponding lead variants to test whether the eQTL effect size was significantly different among conditions. This procedure was equivalent to testing the significance of the interaction term between the condition and lead eQTL variant for each gene. Furthermore, to take advantage of our profiling of gene expression in the same 84 lines in the four conditions, we also included the cell line as a random effect and fitted a linear mixed model by using the lme4 (ref. where (1|cell_line) denotes the cell-line-specific random effect. We then calculated empirical P values for the interaction test by permuting the conditions within each individual line 1,000 times. Subsequently, we used Benjamini-Hochberg FDR correction on the permutation P values to identify 1,950 significant interactions at the 10% FDR level. We used the same normalized data and covariates for interaction testing that were previously used for eQTL mapping in each condition separately.
Detecting response caQTLs. The procedure to identify response caQTLs was almost identical to that used to detect response eQTLs above. However, instead of a linear mixed model, we used a standard linear model without the random effect for cell line, because not all lines were measured in all conditions. Furthermore, we found that our strategy to permute conditions within individual lines was not reliable when the number of measured conditions was not the same for each individual. Therefore, we applied Benjamini-Hochberg FDR correction to nominal P values from the linear model and identify significant interactions at the 10% FDR level.
With this approach, we identified significant interactions for 6,591 caQTL regions.
Filtering and clustering QTLs by effect size. Next, we focused on all significant response eQTLs and response caQTLs that were detected with the interaction test above. We extracted the RASQUAL QTL effect-size estimates π for each featurevariant pair in each condition and converted them to log 2 FC values between the two homozygotes by using the formula log 2 FC = -log 2 (π/ (1-π) ). Multiplication by -1 was necessary because RASQUAL uses alternative allele dosage to represent genotypes, whereas the SNPRelate package that the we used to import genotypes into R uses reference-allele dosage. For a QTL to be considered condition specific, we required the absolute log 2 FC in the naive condition to be < 0.59 (1.5 fold) and the absolute difference in log 2 FC between naive and any one of the stimulated conditions to be > 0.59 (~1.5 fold). We further required the absolute log 2 FC to be > 0.59 in at least one condition. To demonstrate that our results were not sensitive to the exact FC threshold used, we also repeated the same analysis by using a log 2 FC threshold of 1 (= twofold) for all three filters. To obtain the relative log 2 FC, we divided the log 2 FC values in each condition by the maximal log 2 FC value observed across conditions. This scaling was necessary to make QTLs with different absolute effect sizes comparable to one another. Finally, we used k-means clustering to identify six groups of QTLs that had similar activity patterns across conditions.
Identifying master and dependent regions.
For each caQTL region, we defined its credible set of causal variants as those with R 2 > 0.8 to the lead variant. We then classified the focal caQTL region as a master region (i, Fig. 3b ) if the credible set overlapped the region itself, thus suggesting that the caQTL was directly caused by a variant within the region disrupting TF binding. Alternatively, if the credible set overlapped some other regulated region but not the focal region, then we classified it as a dependent region (ii, Fig. 3b ). We also excluded ambiguous cases in which the credible set either overlapped multiple regulated regions (iii, Fig. 3b ) or did not overlap any regulated regions (iv and v, Fig. 3b) . To estimate the fraction of master-dependent region pairs that had the same direction of effect, we limited our analysis to region pairs with a nominal P value of the lead master caQTL variant for both master and dependent regions < 10 . This filtering was necessary to ensure that master and dependent caQTLs were both active in the same condition.
Motif-disruption analysis. We limited motif-disruption analysis to caQTL regions that did not contain associated indels and had three or fewer overlapping SNPs in them. For each SNP and peak pair, we focused on the sequence ± 25 bp from the SNP. We constructed both reference and alternative versions of the sequence and used TFBSTools v1. 10.4 (ref. 72 ) to calculate the relative binding scores for both alleles (expressed as a percentage from 0% to 100%). The TF motifs were downloaded from the CIS-BP 73 database. We considered the variant to be motif disrupting if the difference in the relative binding score between the two alleles was > 3%. We also required the relative binding score for at least one of the alleles to be ≥ 85% of the theoretical maximum. This filter was necessary to exclude potential motif-disruption events in very weak motif matches that were not likely to correspond to binding in vivo and is similar to the default thresholds recommended by TFBSTools. We used Fisher's exact test to identify motifs that were significantly more often disrupted in one of the six condition-specific caQTL clusters compared with all caQTLs. For condition-specific caQTLs, we further limited the analysis to putative master caQTL regions, because they were more likely to contain the causal caQTL variant. We did not use that filter for caQTLs regulating putative primed enhancers, because the number of primed enhancers was much smaller.
Identifying condition-specific dependent regions. To identify condition-specific dependent regions, we tested whether the effect size of the caQTL changed differently for master and dependent regions (2,023 unique pairs) between the two conditions. This procedure was equivalent to testing the significance of a three-way interaction among genotype, region (master or dependent) and condition, and was implemented as the comparison of two standard linear models in R:~+ Similarly to condition-specific caQTL analysis, we used the first three principal components calculated separately for each condition as covariates in the model. For each master and dependent region pair, we picked the minimal P value from three tests (naive versus each simulated condition) and used Bonferroni correction to correct for multiple testing. We then applied Benjamini-Hochberg FDR correction to the Bonferroni-corrected P values to identify all master-dependent region pairs that showed significant interaction at 10% FDR. We used the log 2 FC from RASQUAL as the measure of the caQTL effect size. To identify true conditionspecific dependent regions, we further filtered the results by requiring the absolute log 2 FC of the master region to be > 0.59 (1.5 fold) in the naive condition and the change in the log 2 FC for the dependent region between the naive and stimulated condition to be > 0.59. We also required the change in the log 2 FC for the master peak to be < 1.
Linking response eQTLs to caQTLs. First, we divided all response eQTLs into three groups according to the condition in which they had the maximal effect size (IFNγ , Salmonella or IFNγ + Salmonella). For each response eQTL, we then identified all caQTLs that were in high LD with it in any of the four conditions (R 2 > 0.8 between the lead variants) (Supplementary Fig. 18 ). If there was more than one caQTL in high LD, we picked the one with the smallest association P value to obtain at most one caQTL corresponding to each response eQTL. Next, to estimate the prevalence of enhancer priming, we asked how often the corresponding caQTL was already present in the naive condition. Because response eQTLs were required to have RASQUAL log 2 FC < 0.59 in the naive condition (described above), we used the same threshold to decide whether the caQTL was present (log 2 FC > 0.59) or absent (log 2 FC < 0.59) in the naive condition. We also repeated this analysis, using a more stringent threshold of log 2 FC > 1. Because there are various reasons why this analysis might lead to false positives, we quantified our false-positive rate by performing a reverse analysis in which we started with response caQTLs, identified corresponding eQTLs (R 2 > 0.8) and asked how often the eQTLs were already present in the naive condition (log 2 FC > 0.59).
Colocalization with GWAS hits. We used coloc v2.3-1 (ref. 30 ) to test for colocalization between molecular QTLs and GWAS hits. In the colocalization analysis, we used summary statistics from the linear model (rather than RASQUAL), because RASQUAL summary statistics could not be easily converted into approximate Bayes factors required by coloc. We ran coloc on a 400-kb region centered on each lead eQTL and caQTL variant (200 kb for the secondary eQTLs) that was less than 100 kb away from at least one GWAS variant with a nominal P value < 10 −5
. We then applied a set of filtering steps to identify a stringent set of eQTLs and caQTL that colocalized with GWAS hits. Similarly to a published analysis 40 , we first removed all cases in which PP3 + PP4 < 0.8, to exclude loci where we were underpowered to detect colocalization. We then required PP4/(PP3 + PP4) > 0.9, to keep only loci where coloc strongly preferred the model of a single shared causal variant driving both association signals (PP4) over a model of two distinct causal variants (PP3). We excluded all colocalization results from the MHC region (GRCh38 chromosome 6: 28510120-33480577) because they were likely to be false positives, owing to complicated LD patterns in this region. We kept only results in which the minimal GWAS P value was < 10 −6
. Finally, we manually excluded 11 potential eQTL overlaps and six potential caQTL overlaps in which, on visual inspection, the LD block exceeded the 400-kb window that we used for colocalization testing.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
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Experimental design 1. Sample size
Describe how sample size was determined.
The final sample size was decided based on similar gene expression and chromatin QTL mapping studies performed previously. We also performed sub-sampling analysis on a larger response eQTL dataset to empirical estimate our statistical power (Supplementary Note).
Data exclusions
Describe any data exclusions.
Data quality control and sample exclusion criteria are described in Online Methods in sections 'RNA-seq preprocessing and quality control' and 'ATAC-seq data analysis'.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
We did not perform full experimental replication of our QTL analysis, but we used subsampling analysis on a larger response eQTL dataset to verify that our analysis was not subject to false positives due to a small sample size.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
All cell lines were included in all experimental groups (Supplementary Note).
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was used, because all cell lines were included in all experimental groups (Supplementary Note).
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided 
